The combined treatment with L-arginine and methylprednisolone improves graft morphology and mucosal barrier function.
Warnecke
H B
HB
Department of Surgery, Humboldt University of Berlin, Berlin, Germany.
Schirmeier
A
A
Nüssler
A K
AK
Platz
K P
KP
Stange
B
B
Nüssler
N C
NC
Radke
C
C
Neuhaus
P
P
Mueller
A R
AR
D000818:Animals; D001120:Arginine / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000502:physiology* / Q000637:transplantation; D007421:Intestine, Small / Q000187:drug effects / Q000502:physiology / Q000637:transplantation*; D008775:Methylprednisolone / Q000494:pharmacology*; D008981:Molsidomine / Q000494:pharmacology; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000517:prevention & control*; D014185:Transplantation, Isogeneic / Q000473:pathology / Q000502:physiology*; D014665:Vasodilator Agents / Q000494:pharmacology
D014665:Vasodilator Agents; D001120:Arginine; D008981:Molsidomine; D008775:Methylprednisolone